Nanoparticle formulation of ormeloxifene for pancreatic cancer

Pancreatic cancer is the fourth most prevalent cancer with about an 85% mortality rate; thus, an utmost need exists to discover new therapeutic modalities that would enhance therapy outcomes of this disease with minimal or no side effects. Ormeloxifene (ORM), a synthetic molecule, has exhibited pote...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomaterials
Hauptverfasser: Khan, Sheema, Chauhan, Neeraj, Yallapu, Murali M., Ebeling, Mara C., Balakrishna, Swathi, Ellis, Robert T., Thompson, Paul A., Balabathula, Pavan, Behrman, Stephen W., Zafar, Nadeem, Singh, Man Mohan, Halaweish, Fathi T., Jaggi, Meena, Chauhan, Subhash C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2015
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405677/
https://ncbi.nlm.nih.gov/pubmed/25890768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.02.082
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge